FNCH
Vanguard Group’s Finch Therapeutics Group, Inc. Common Stock FNCH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-36,252
| Closed | -$94.3K | – | 4518 |
|
|
2024
Q1 | $94.3K | Sell |
36,252
-2,512
| -6% | -$6.53K | ﹤0.01% | 4251 |
|
|
2023
Q4 | $140K | Buy |
38,764
+2,825
| +8% | +$10.2K | ﹤0.01% | 4264 |
|
|
2023
Q3 | $186K | Buy |
35,939
+3,263
| +10% | +$16.9K | ﹤0.01% | 4260 |
|
|
2023
Q2 | $279K | Sell |
32,676
-982,328
| -97% | -$8.38M | ﹤0.01% | 4255 |
|
|
2023
Q1 | $399K | Hold |
1,015,004
| – | – | ﹤0.01% | 4183 |
|
|
2022
Q4 | $487K | Buy |
1,015,004
+4,870
| +0.5% | +$2.34K | ﹤0.01% | 4107 |
|
|
2022
Q3 | $1.69M | Hold |
1,010,134
| – | – | ﹤0.01% | 3812 |
|
|
2022
Q2 | $2.87M | Buy |
1,010,134
+215,835
| +27% | +$613K | ﹤0.01% | 3648 |
|
|
2022
Q1 | $3.99M | Sell |
794,299
-2,649
| -0.3% | -$13.3K | ﹤0.01% | 3634 |
|
|
2021
Q4 | $7.95M | Buy |
796,948
+620,019
| +350% | +$6.18M | ﹤0.01% | 3350 |
|
|
2021
Q3 | $2.3M | Buy |
176,929
+2,134
| +1% | +$27.8K | ﹤0.01% | 4018 |
|
|
2021
Q2 | $2.46M | Buy |
174,795
+139,795
| +399% | +$1.97M | ﹤0.01% | 3911 |
|
|
2021
Q1 | $565K | Buy |
+35,000
| New | +$565K | ﹤0.01% | 4113 |
|